New: NCI-funded clinical trial search
Mednet Logo
CommunityHematology

For atrial fibrillation patients with high risk of CVA who cannot tolerate full dose AC due to bleeding, do you consider low dose/extended dosing anticoagulation even if they do not meet age/GFR criteria for a dose reduction, if Watchman is not readily available as an option?

1 Answer
Mednet MemberInvited Expert
Cardiology · Lankenau Heart Group
Answered on

Most drugs, including anticoagulants, have a dose-response. Therefore, one could argue that even though DOACs were not studied at low doses, except in defined sub-groups such as the very elderly, using such a dose in other situations may have some benefit. The problem is that without data, we simply cannot be assured that any putative reduction of stroke and systemic embolism outstrips the risk, which may be mortal bleeding. Therefore, I generally discourage low-dose strategies, which, unfortunately, are used inappropriately in up to 25% of ordinary patients. Having said that, in extraordinary situations such as the one described, it is conscionable to consider a lower dose for stroke protection, but only with full disclosure to and discuss...

Join for free or sign in to see the full answer